Coronavirus Update: Hudson’s Remarks On US ‘First Rights’ Stirs Vaccine Row

Draws Criticism From French Government

Company clarifies by saying it has production capacity in Europe as well as US and other regions - but follows Hudson's calls for Europe to develop its own BARDA-like agency.  

Sanofi_France

Controversy around how any future COVID-19 vaccines should be allocated between countries has been fueled by Sanofi’s CEO after he said the US would have priority for his company's product.

Paul Hudson said longstanding funding from the US Biomedical Advanced Research and Development Authority (BARDA), which expanded its partnership with...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip